Stockreport

UroGen Pharma Reports Third Quarter 2021 Financial Results and Recent Corporate Developments

UroGen Pharma Ltd. - Ordinary Shares  (URGN) 
Last urogen pharma ltd. - ordinary shares earnings: 3/2 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.urogen.com
PDF Shift to single-arm Phase 3 study for UGN-102 in bladder cancer streamlines pivotal study to form basis of FDA submissionJelmyto® net product revenue of $11.4 million fo [Read more]